1887

Abstract

Adenovirus-based gene therapy vectors now in use cannot be targeted to specific cell types and are immunogenic, properties which limit their clinical utility. Improved vectors lacking the genes for viral structural proteins may overcome these limitations. We have developed cell lines which stably express the adenovirus type 5 (Ad5) fibre protein in its native trimeric form. These cells can complement an Ad5 mutant with a defect in the fibre gene, and are capable of incorporating the Ad5 fibre into particles of a different Ad serotype. As the fibre protein is responsible for the initial binding of virus to cells, packaging cell lines expressing different or modified fibre proteins will be useful in studying the mechanism by which adenovirus infects different cell types.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-79-6-1461
1998-06-01
2022-05-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/79/6/9634089.html?itemId=/content/journal/jgv/10.1099/0022-1317-79-6-1461&mimeType=html&fmt=ahah

References

  1. Akusjärvi G., Pettersson U. 1979; Sequence analysis of adenovirus DNA: complete nucleotide sequence of the spliced 5′ noncoding region of adenovirus 2 hexon messenger RNA. Cell 16:841–850
    [Google Scholar]
  2. Amalfitano A., Begy C. R., Chamberlain J. S. 1996; Improved adenovirus packaging cell lines to support the growth of replication- defective gene-delivery vectors. Proceedings of the National Academy of Sciences, USA 93:3352–3356
    [Google Scholar]
  3. Arnberg N., Mei Y.-F., Wadell G. 1997; Fiber genes of adenoviruses with tropism for the eye and the genital tract. Virology 227:239–244
    [Google Scholar]
  4. Bergelson J. M., Cunningham J. A., Droguett G., Kurt-Jones E. A., Krithivas A., Hong J. S., Horwitz M. S., Crowell R. L., Finberg R. W. 1997; Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320–1323
    [Google Scholar]
  5. Brough D. E., Lizonova A., Hsu C., Kulesa V. A., Kovesdi I. 1996; A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4. Journal of Virology 70:6497–6501
    [Google Scholar]
  6. Caravokyri C., Leppard K. N. 1995; Constitutive episomal expression of polypeptide IX (pIX) in a 293-based cell line complements the deficiency of pIX mutant adenovirus type 5. Journal of Virology 69:6627–6633
    [Google Scholar]
  7. Chee-Sheung C. C., Ginsberg H. S. 1982; Characterization of a temperature-sensitive fiber mutant of type 5 adenovirus and effect of the mutations on virion assembly. Journal of Virology 42:932–950
    [Google Scholar]
  8. Chow L. T., Gelinas R. E., Broker T. R., Roberts R. J. 1997; An amazing sequence arrangement at the 5′ ends of adenovirus 2 messenger RNA. Cell 12:1–8
    [Google Scholar]
  9. Chroboczek J., Bieber F., Jacrot B. 1992; The sequence of the genome of adenovirus type 5 and its comparison with the genome of adenovirus type 2. Virology 186:280–285
    [Google Scholar]
  10. Chroboczek J., Ruigrok R. W. H., Cusack S. 1995; Adenovirus fiber. In The Molecular Repertoire of Adenoviruses pp. 164–200 Doerfler W., Bohm P. Edited by Berlin: Springer-Verlag;
    [Google Scholar]
  11. Dai Y., Schwarz E. M., Gu D., Zhang W.-W., Sarvetnick N., Verma I. M. 1997; Cellular and humoral immune responses to adenoviral vectors containing factor IX gene : tolerization of factor IX and vector antigens allows for long-term expression. Proceedings of the National Academy of Sciences, USA 92:1401–1405
    [Google Scholar]
  12. Dolph P. J., Racaniello V., Villamarin A., Palladino F., Schneider R. J. 1988; The adenovirus tripartite leader may eliminate the requirement for cap-binding protein complex during translation initiation. Journal of Virology 62:2059–2066
    [Google Scholar]
  13. Engelhardt J. F., Ye X., Doranz B., Wilson J. M. 1994; Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proceedings of the National Academy of Sciences, USA 91:6196–6200
    [Google Scholar]
  14. Fender P., Ruigrok R. W. H., Gout E., Buffet S., Chroboczek J. 1997; Adenovirus dodecahedron, a new vector for human gene transfer. Nature Biotechnology 15:52–56
    [Google Scholar]
  15. Fisher K. J., Choi H., Burda J., Chen S.-J., Wilson J. M. 1996; Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology 217:11–22
    [Google Scholar]
  16. Gall J., Kass-Eisler A., Leinwand L., Falck-Pedersen E. 1996; Adenovirus type 5 and 7 capsid chimera : fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes. Journal of Virology 70:2116–2123
    [Google Scholar]
  17. Gorziglia M. I., Kadan M. J., Yei S., Lim J., Lee G. M., Luthra R., Trapnell B. C. 1996; Elimination of both E1 and E2a from adenovirus vectors further improves prospects for in vivo human gene therapy. Journal of Virology 70:4173–4178
    [Google Scholar]
  18. Graham F. L., Smiley J., Russell W. C., Nairn R. 1977; Characteristics of a human cell line transformed by DNA from human adenovirus type 5. Journal of General Virology 36:59–72
    [Google Scholar]
  19. Haecker S. E., Stedman H. H., Balice-Gordon R. J., Smith D. B. J., Greelish J. P., Mitchell M. A., Wells A., Sweeney H. L., Wilson J. M. 1996; In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes. Human Gene Therapy 7:1907–1914
    [Google Scholar]
  20. Harlow E., Lane D. 1988 Antibodies Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
  21. Henry L. J., Xia D., Wilke M. E., Deisenhofer J., Gerard R. D. 1994; Characterization of the knob domain of the adenovirus type 5 fiber protein expressed in Escherichia coli . Journal of Virology 68:5239–5246
    [Google Scholar]
  22. Huang S., Kamata T., Takada Y., Ruggeri Z. M., Nemerow G. R. 1996; Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells. Journal of Virology 70:4502–4508
    [Google Scholar]
  23. Kochanek S., Clemens P. R., Mitani K., Chen H.-H., Chan S., Caskey C. T. 1997; A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and β-galactosidase. Proceedings of the National Academy of Sciences, USA 93:5731–5736
    [Google Scholar]
  24. Kozak M. 1986; Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44:283–292
    [Google Scholar]
  25. Kozarsky K. F., Wilson J. M. 1993; Gene therapy: adenovirus vectors. Current Opinion in Genetics and Development 3:499–503
    [Google Scholar]
  26. Krasnykh V. N., Mikheeva G. V., Douglas J. T., Curiel D. T. 1996; Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. Journal of Virology 70:6839–6846
    [Google Scholar]
  27. Krougliak V., Graham F. L. 1995; Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants. Human Gene Therapy 6:1575–1586
    [Google Scholar]
  28. Kumar-Singh R., Chamberlain J. S. 1997; Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells. Human Molecular Genetics 5:913–921
    [Google Scholar]
  29. Langer S. J., Schaack J. 1996; 293 cell lines that inducibly express high levels of adenovirus type 5 precursor terminal protein. Virology 221:172–179
    [Google Scholar]
  30. Levine A. J., Ginsberg H. S. 1967; Mechanism by which fiber antigen inhibits multiplication of type 5 adenovirus. Journal of Virology 1:747–757
    [Google Scholar]
  31. Michael S. I., Hong J. S., Curiel D. T., Engler J. A. 1995; Addition of a short peptide ligand to the adenovirus fiber protein. Gene Therapy 2:660–668
    [Google Scholar]
  32. Mitani K., Graham F. L., Caskey C. T., Kochanek S. 1995; Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector. Proceedings of the National Academy of Sciences, USA 92:3854–3858
    [Google Scholar]
  33. Novelli A., Boulanger P. A. 1991; Deletion analysis of functional domains in baculovirus-expressed adenovirus type 2 fiber. Virology 185:365–376
    [Google Scholar]
  34. Philipson L., Lonberg-Holm K., Petterson U. 1968; Virus-receptor interaction in an adenovirus system. Journal of Virology 2:1064–1075
    [Google Scholar]
  35. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
  36. Schaack J., Guo X., Yew-WaiHo W., Karlok M., Chen C., Ornelles D. 1995; Adenovirus type 5 precursor terminal protein-expressing 293 and HeLa cell lines. Journal of Virology 69:4079–4085
    [Google Scholar]
  37. Sheay W., Nelson S., Martinez I., Chu T.-H.T., Bhatia S., Dornburg R. 1993; Downstream insertion of the adenovirus tripartite leader sequence enhances expression in universal eukaryotic vectors. BioTechniques 15:856–862
    [Google Scholar]
  38. Stevenson S. C., Rollence M., White B., Weaver L., McClelland A. 1995; Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain. Journal of Virology 69:2850–2857
    [Google Scholar]
  39. Stevenson S. C., Rollence M., Marshall-Neff J., McClelland A. 1997; Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein. Journal of Virology 71:4782–4790
    [Google Scholar]
  40. Stratford-Perricaudet L. D., Makeh I., Perricaudet M., Briand P. 1992; Widespread long-term gene transfer to mouse skeletal muscles and heart. Journal of Clinical Investigation 90:626–630
    [Google Scholar]
  41. Thiel J. F., Smith K. O. 1967; Fluorescent focus assay of viruses on cell monolayers in plastic Petri plates. Proceedings of the Society for Experimental Biology and Medicine 125:892–895
    [Google Scholar]
  42. Tomko R. P., Xu R., Philipson L. 1997; HCAR and MAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proceedings of the National Academy of Sciences, USA 94:3352–3356
    [Google Scholar]
  43. Wang Q., Jia X.-C., Finer M. H. 1995; A packaging cell line for propagation of recombinant adenovirus vectors containing two lethal gene-region deletions. Gene Therapy 2:775–783
    [Google Scholar]
  44. Weinberg D. H., Ketner G. 1983; A cell line that supports the growth of a defective early region 4 deletion mutant of human adenovirus type 2. Proceedings of the National Academy of Sciences, USA 80:5383–5386
    [Google Scholar]
  45. Wickham T. J., Mathias P., Cheresh D. A., Nemerow G. R. 1993; Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment. Cell 73:309–319
    [Google Scholar]
  46. Yang Y., Nunes F., Berencsi K., Furth E. E., Gönczöl E., Wilson J. M. 1994; Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proceedings of the National Academy of Sciences, USA 91:4407–4411
    [Google Scholar]
  47. Yang Y., Su Q., Wilson J. M. 1996; Role of viral antigens in destructive cellular immune responses to adenovirus-transduced cells in mouse lungs. Journal of Virology 70:7209–7212
    [Google Scholar]
  48. Yeh P., Dedieu J.-F., Orsini C., Vigne E., Denefle P., Perricaudet M. 1996; Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit. Journal of Virology 70:559–565
    [Google Scholar]
  49. Zhang Y., Feigenblum D., Schneider R. J. 1994; A late adenovirus factor induces eIF-4E dephosphorylation and inhibition of cell protein synthesis. Journal of Virology 68:7040–7050
    [Google Scholar]
  50. Zhou H., O’Neal W., Morral N., Beaudet A. L. 1996; Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted. Journal of Virology 70:7030–7038
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-79-6-1461
Loading
/content/journal/jgv/10.1099/0022-1317-79-6-1461
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error